Most people barely register an extra handful of chips at 11 p.m. But 50 to 100 surplus calories a day, compounded over a decade, is how most weight gain actually happens — not through dramatic binges, but through a slow, invisible drift. The European Commission has now authorized a food ingredient specifically designed to interrupt that drift. Inulin propionate ester, or IPE, combines inulin (a soluble fiber found in chicory and onions) with propionate (a short-chain fatty acid your gut bacteria already produce when they ferment fiber). The ester bond ensures propionate reaches the colon intact, where it triggers GLP-1 and PYY — the same satiety hormones targeted by weight-loss injections costing north of $1,000 a month. Think of it as the difference between trickle-charging and fast-charging your body’s fullness signal.
In a 24-week trial of overweight, middle-aged adults, participants taking 10 grams of IPE daily gained significantly less weight and accumulated less visceral abdominal fat than those receiving plain inulin, according to research published in Gut. Acute feeding studies showed roughly 14% fewer calories consumed at meals. Brain imaging from the same Imperial College London team revealed reduced activity in reward-processing regions when participants viewed high-calorie food.
“Randomized controlled trials by the team have shown that around 10 grams of IPE per day can regulate appetite and help prevent weight gain.” — Professor Gary Frost, Imperial College London
The Fine Print
A longer trial in younger adults found no meaningful weight-control benefit, raising questions about who actually benefits.
Not every study tells the same story. A 12-month trial in younger adults with overweight found no significant difference in weight gain control between IPE and inulin alone — a result suggesting the ingredient’s effects may be age- or context-dependent. Some researchers question whether IPE offers meaningful advantages over simply eating more fiber. Independent nutrition scientists note that standard high-fibre diets already confer similar endocrine and satiety benefits, and the degree of incremental gain from IPE remains an open question.
“IPE could help stop the kind of slow, steady weight gain that makes those drugs necessary.” — Professor Douglas Morrison, University of Glasgow
Fifteen years of development and six years of EFSA review brought IPE to this point. The spinout company Satisfed now needs industrial partners to scale production from hundreds of kilograms to thousands of tonnes. If costs stay low, IPE could land in your morning cereal or smoothie — a quiet dietary nudge aimed especially at communities where healthy food access is already limited.
IPE occupies the uncomfortable space between “eat more vegetables” advice nobody follows and a GLP-1 prescription not everyone can get. Whether it fills that gap depends on scale, cost, and clearer answers about exactly who benefits. The EU approval is step one. The hard part starts now.
